Quick Answer
Immuneering Corp reported Total Revenue of $0.00 for fiscal year 2023.
Immuneering Corp Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2023 | $0.00 | -100.0% |
| 2022 | $317.0K | -84.8% |
| 2021 | $2.08M | -10.0% |
| 2020 | $2.31M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $0.00 | -100.0% | — |
| June 30, 2023 | $0.00 | -100.0% | — |
| March 31, 2023 | $0.00 | -100.0% | -100.0% |
| September 30, 2022 | $38.4K | -92.0% | -59.4% |
| June 30, 2022 | $94.4K | -85.7% | -48.6% |
| March 31, 2022 | $183.7K | -75.4% | -61.9% |
| September 30, 2021 | $482.1K | -29.4% | -27.0% |
| June 30, 2021 | $660.0K | +37.3% | -11.8% |
- Immuneering Corp showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2023 period, Immuneering Corp’s total revenue has declined by 100.0% (from $2.31 million to $0.00).
- The most recent figure is from Immuneering Corp’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 1, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: